COMPARATIVE ANALYSIS OF THE FLUCONAZOLE SUSCEPTIBILITY OF CLINICAL ISOLATES OF CANDIDA ALBICANS

Download full text PDF
Issue: 
5
Year: 
2017

V. Novikova (1), P. Zubov (1); O. Startseva (2) 1-Perm State Pharmaceutical Academy, Ministry of Health of Russia 2-OOO «Laboratory Technologies», Perm

A microdilution method was used to investigate the susceptibility of the clinical isolates of Candida albicans from vaginal discharge to the commonly used antifungal medication fluconazole. The findings were compared with the data obtained when using the disk diffusion method.

Keywords: 
gynecology
vulvovaginal candidiasis
Candida albicans
antifungals
fluconazole



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Veselov A.V., Kozlov R.S. Invazivnyj kandidoz: sovremennye aspekty epidemiologii, diagnostiki, terapii i profilaktiki u razlichnyh kategorij patsientov // Klin. mikrobiol. i antimikrob. himioter. – 2016; 18 (2, Pril. 2): 1–104.
  2. Dolgo-Saburova Ju.V., Mirzabalaeva A.K., Klimko N.N. O probleme rezistentnosti vozbuditelej retsidivirujuschego vul'vovaginal'nogo kandidoza // Ginekologija. – 2014; 16 (1): 3–6.
  3. Veselov A.V., Klimko N.N., Krechikova O.I. i dr. In vitro aktivnost' flukonazola i vorikonazola v otnoshenii bolee 10000 shtammov drozhzhej: rezul'taty 5-letnego prospektivnogo issledovanija ARTEMIS disk v Rossii // Klin. mikrobiol. i antimikrob. himioter. – 2008; 10 (4): 345–54.
  4. Ankirskaja A.S., Murav'eva V.V., Fursova S.A. i dr. Monitoring vidovogo sostava i chuvstvitel'nosti k antimikotikam drozhzhepodobnyh gribov, vydelennyh iz vlagalischa zhenschin reproduktivnogo vozrasta // Klin. mikrobiol. i antimikrob. himioter. – 2006; 8 (1): 87–95.
  5. Opredelenie chuvstvitel'nosti k mikroorganizmov k antibakterial'nym preparatam: metodicheskie ukazanija / MUK 4.2.1890-04. Utv. 04.03.2004.
  6. Opredelenie chuvstvitel'nosti mikroorganizmov k antimikrobnym preparatam: klinicheskie rekomendatsii, 2015. URL: http://www.antibiotic.ru/minzdrav/clinical- recommendations.
  7. Prilepskaja V.N., Bajramova G.R. Vul'vovaginal'nyj kandidoz. Klinika, diagnostika, printsipy terapii / M., 2010; 72 s.
  8. Klimko N.N., Kozlova Ja.I., Vasil'eva N.V i dr. Rasprostranennost' tjazhelyh i hronicheskih mikoticheskih zabolevanij v Rossijskoj Federatsii po modeli LIFE program // Probl. med. mikol. – 2014; 16 (1): 3–8.
  9. Rukovodstvo po provedeniju doklinicheskih issledovanij lekarstvennyh sredstv. Ch. 1 / M.: Grif i K, 2012; 944 s.
  10. Veselov A.V., Multyh I.G., Kljasova G.A. i dr. Epidemiologija vozbuditelej kandidozov i ih chuvstvitel'nost' k azolam: rezul'taty issledovanija ARTEMIS Disk v Rossii // Klin. mikrobiol. i antimikrob. himioter. – 2005; 7 (1): 68–76.
  11. Bary A., Brown D. Fluconazole disk diffusion procedure for determining susceptibility of Candida species // J. Clin. Microbiol. – 1996; 34: 2154–7.
  12. Cardo D., Horan T., Andrus M. et al. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. A report from the NNIS System // J. Infect. Control. – 2004; 32: 470–85.
  13. Leroy O., Gangneux J.-P. et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) // Crit. Care Med. – 2009; 37: 1612–8.
  14. Marchaim D., Lemanek L., Bheemreddy S. et al. Fluconazole-Resistant Candida albicans Vulvovaginitis // Obstet. Gynecol. – 2012; 120 (6): 1407–14.
  15. Mohanty S., Xess I., Hasan F. et al. Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis // Indian J. Med. Res. – 2007; 126: 216–9.
  16. Peman J., Canton E., Espinel-Ingroff A. Antifungal drug resistance mechanisms // Exp. Rev. Anti-Infect. Ther. – 2009; 7 (4): 453–60.
  17. Sobel J. Vulvovaginal candidosis // Lancet. – 2007; 369 (9577): 1961–71.